{{one source|date=August 2014}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 462093329
| IUPAC_name = (''RS'')-1-Ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid
| image = Lomefloxacin.svg
| image2 = Lomefloxacin ball-and-stick.png
<!--Clinical data-->
| tradename = Maxaquin
| Drugs.com = {{drugs.com|CDI|lomefloxacin}}
| MedlinePlus = a600002
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = 10%
| metabolism =  
| elimination_half-life = 8 hours
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 98079-51-7
| ATC_prefix = J01
| ATC_suffix = MA07
| ATC_supplemental =  {{ATC|S01|AE04}}
| PubChem = 3948
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00978
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3811
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9VC7S3ZXXB
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02318
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 116278
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 561
<!--Chemical data-->
| C=17 | H=19 | F=2 | N=3 | O=3
| molecular_weight = 351.348 g/mol
| smiles = Fc1c(c(F)c2c(c1)C(=O)C(\C(=O)O)=C/N2CC)N3CC(NCC3)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZEKZLJVOYLTDKK-UHFFFAOYSA-N
}}

'''Lomefloxacin hydrochloride''' (sold under the following brand names in English speaking countries '''Maxaquin''', '''Okacyn''', '''Uniquin''') is a [[fluoroquinolone]] [[antibiotic]] used to treat [[bacteria]]l infections including [[bronchitis]] and [[urinary tract infection]]s. It is also used to prevent urinary tract infections prior to [[surgery]]. Lomefloxacin is associated with [[phototoxicity]] and [[central nervous system]] adverse effects.<ref>{{Cite journal  | last1 = Rubinstein | first1 = E. | title = History of quinolones and their side effects. | journal = Chemotherapy | volume = 47 | issue =Suppl 3  | pages = 3–8; discussion 44–8  | year = 2001 | doi =  10.1159/000057838| pmid = 11549783 }}</ref>

October 2008 the FDA added the following [[black box warning]] to the product insert for Maxaquin:  ''Lomefloxacin is unique in that it forms a magnesium [[chelate]] with itself. The chelate is formed between the 2-carbonyl group of two separate lomefloxacin molecules.''

==See also==
*[[Quinolones]]

==References==
{{reflist}}

{{QuinoloneAntiBiotics}}

[[Category:Fluoroquinolone antibiotics]]
[[Category:Piperazines]]
[[Category:Carboxylic acids]]

{{antibiotic-stub}}